Balefire, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1750924 DALLAS, TX

Position in BMY

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$1,054,388

-$33,369 QoQ

Shares Held

18,299

+2.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#1,135

of 2,506 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Balefire, LLC holds $12,645,380 across 10 Drug Manufacturers - General names. BMY ranks #5 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,262	$5,111,971
2	JNJ	Johnson & Johnson	5,701	$1,447,882
3	MRK	Merck & Co., Inc.	10,039	$1,290,011
4	AMGN	Amgen Inc	3,296	$1,193,547
5	BMY	Bristol Myers Squibb Co This page	18,299	$1,054,388
6	ABBV	AbbVie Inc.	3,997	$1,005,805
7	GILD	Gilead Sciences, Inc.	5,982	$755,765
8	AZN	Astrazeneca PLC	1,645	$311,924

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,054,388	18,299	+2.0%	Shares	Sole	2026-07-07
2026-03-31	$1,087,757	17,935	-16.9%	Shares	Sole	2026-05-07
2025-12-31	$1,164,240	21,584	+3.4%	Shares	Sole	2026-01-12
2025-09-30	$941,101	20,867	+7.1%	Shares	Sole	2025-10-08
2025-06-30	$901,868	19,483	-26.8%	Shares	Sole	2025-07-09
2025-03-31	$1,622,577	26,604	+3.6%	Shares	Sole	2025-04-23
2024-12-31	$1,452,291	25,677	+30.5%	Shares	Sole	2025-02-03
2024-09-30	$1,017,932	19,674	+4540.1%	Shares	Sole	2024-10-15
2024-03-31	$22,993	424	+18.1%	Shares	Sole	2024-05-10
2023-12-31	$18,420	359	-51.3%	Shares	Sole	2024-02-07
2023-09-30	$42,775	737	+300.5%	Shares	Sole	2023-12-06
2023-06-30	$11,766	184	-96.4%	Shares	Sole	2023-08-21
2020-12-31	$319,268	5,147	-80.3%	Shares	Sole	2021-02-08
2020-09-30	$1,572,242	26,078	-34.8%	Shares	Sole	2020-11-12
2020-06-30	$2,353,234	40,021	-7.4%	Shares	Sole	2020-08-14
2020-03-31	$2,408,581	43,211	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.